DCGI tells aesthetic clinics, beauty brands: cosmetics are for beautifying, not treatment
India's drug regulator issued a public notice warning cosmetics manufacturers, importers and aesthetic clinics against marketing products as injectables or therapeutic treatments. Notice flags misleading claims, prohibited ingredients and label tampering under the Drugs and Cosmetics Act — putting premium beauty and derma-cosmetic brands on notice.
What happened
CDSCO · DCGI issued a public notice clarifying cosmetics cannot be used as injectables or for treatment, warning manufacturers, importers, and aesthetic clinics
Why this matters
Diligence on beauty and aesthetic targets must price in claims-compliance remediation costs and potential label, SKU, and clinic-protocol overhauls under the Drugs and Cosmetics Act.